Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Peripheral Soluble Immune Checkpoint-Related Proteins Were Associated with Survival and Treatment Efficacy of Osteosarcoma Patients, a Cohort Study. | Cancers (Basel) | 2024 | 38730580 | PubTator, text mining | PubMed |
| Single-cell BCR and transcriptome analysis reveals peripheral immune signatures in patients with thyroid-associated ophthalmopathy. | Aging (Albany NY) | 2024 | 38728262 | PubTator, text mining | PubMed |
| Association of immune cells and the risk of esophageal cancer: A Mendelian randomization study in a East Asian population. | Medicine (Baltimore) | 2024 | 38701252 | PubTator, text mining | PubMed |
| B- and T-Lymphocyte Attenuator in Systemic Lupus Erythematosus Disease Pathogenesis. | Clin Pharmacol Ther | 2024 | 38676311 | PubTator, text mining | PubMed |
| High dimensional proteomic mapping of bone marrow immune characteristics in immune thrombocytopenia. | Sci China Life Sci | 2024 | 38644444 | PubTator, text mining | PubMed |
| Serum Induces the Subunit-Specific Activation of NF-κB in Proliferating Human Cardiac Stem Cells. | Int J Mol Sci | 2024 | 38612406 | PubTator, text mining | PubMed |
| Plasma galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV. | AIDS | 2024 | 38608008 | PubTator, text mining | PubMed |
| Development of a novel, high-efficacy oncolytic herpes simplex virus type 1 platform equipped with two distinct retargeting modalities. | Mol Ther Oncol | 2024 | 38596302 | PubTator, text mining | PubMed |
| Exploring the Role and Prognostic Value of TMEM208 in Head and Neck Squamous Cell Carcinoma. | Asian Pac J Cancer Prev | 2024 | 38546073 | PubTator, text mining | PubMed |
| Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer. | Altern Ther Health Med | 2024 | 38518167 | PubTator, text mining | PubMed |
| Viewing the immune checkpoint VISTA: landscape and outcomes across cancers. | ESMO Open | 2024 | 38503143 | PubTator, text mining | PubMed |
| The role of the BTLA-HVEM complex in the pathogenesis of breast cancer. | Breast Cancer | 2024 | 38483699 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes. | Chem Biol Interact | 2024 | 38460933 | PubTator, text mining | PubMed |
| Association of immune cell traits with Parkinson's disease: a Mendelian randomization study. | Front Aging Neurosci | 2024 | 38455666 | PubTator, text mining | PubMed |
| Deciphering the tumor immune microenvironment of imatinib-resistance in advanced gastrointestinal stromal tumors at single-cell resolution. | Cell Death Dis | 2024 | 38443340 | PubTator, text mining | PubMed |
| Association between circulating immune cells and the risk of prostate cancer: a Mendelian randomization study. | Front Endocrinol (Lausanne) | 2024 | 38405157 | PubTator, text mining | PubMed |
| The BTLA-HVEM complex - The future of cancer immunotherapy. | Eur J Med Chem | 2024 | 38387336 | PubTator, text mining | PubMed |
| LIGHT signaling through LTβR and HVEM in keratinocytes promotes psoriasis and atopic dermatitis-like skin inflammation. | J Autoimmun | 2024 | 38368767 | PubTator, text mining | PubMed |
| Cross-talk between disulfidptosis and immune check point genes defines the tumor microenvironment for the prediction of prognosis and immunotherapies in glioblastoma. | Sci Rep | 2024 | 38365809 | PubTator, text mining | PubMed |
| Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools. | Int J Mol Sci | 2024 | 38339078 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=12